prostate cancer | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added Feb 01, 2022
Evaluating the effects of enzalutamide on the health-related quality of life in patients with metastatic hormone-sensitive prostate cancer.
This study reported the long-term effects on the health-related quality of life (HR-QoL) of enzalutamide (Xtandi) in combination with androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that enzalutamide preserved the overall health and quality of life in these patients.
prostate cancer | Medivizor | source: Medivizor | Added Jan 29, 2022
Cancer Vaccines
When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill. Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcher
prostate cancer | Clinical Trial | Added Jan 28, 2022
Searching for patients with metastatic prostate cancer to test this new treatment combination
This phase 3 trial is examining the effectiveness and safety of niraparib (Zejula) in combination with abiraterone acetate (Zytiga) and prednisone (Deltasone) vs abiraterone acetate and prednisone plus placebo for patients with metastatic prostate cancer. The main outcome to be measured will be the survival time without cancer growing or spreading.
prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jan 10, 2022
Comparing the effectiveness of PARP inhibitors for the treatment of patients with BRCA1 and BRCA2 mutations.
This study compared the effectiveness of PARP inhibitors for the treatment of patients with BRCA1 and BRCA2 mutations in solid tumors. The data showed that PARP inhibitors could benefit both patients with BRCA1 and BRCA2 mutations with similar effectiveness.
prostate cancer | Medivizor | source: Medivizor | Added Dec 14, 2021
Guest Post: Cancer On Facebook--A Patient's Perspective
Dawn Goo is a waitress, former comedian, breast cancer survivor and is now under treatment for Non Hodgkins Lymphoma. She lives in El Paso, Texas. This is a post from her Facebook page which is gathering momentum in social media among people who have experienced cancer, especially those who areprostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Nov 29, 2021
Evaluating the effectiveness of androgen receptor-targeted therapy plus radiotherapy in patients with metastatic castration resistant prostate cancer.
This study evaluated the effectiveness of radiotherapy (RT) plus androgen receptor-targeted therapy (ARTT) on oligo-progressive sites for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC). The data showed that RT on oligo-progressive sites was safe and effective in prolonging treatment with ARTT in patients with mCRPC.
prostate cancer | Medivizor | source: Medivizor | Added Nov 27, 2021
More Free Vacations For Adults With Cancer: Wish Foundations
We are adding to the list of respite opportunities that are available for adults with cancer. In addition to a couple of programs like the ones featured in Free Vacations for Adults affected by Cancer, there are a few foundations for adults with cancer that are much like the well-known Make-A-Wishprostate cancer | Medivizor | source: Medivizor | Added Nov 25, 2021
Infographic on Cancer Immunotherapy
Last summer we provided a series of posts on oncology basics. Oncology Basics: Preparing for ASCO covered some of the history of oncology. In Understanding Cells, we reviewed what is newly understood about cells--it's way beyond what you learned in high school biology. DNA with lots of animated videos also explained someprostate cancer | Medivizor | source: Medivizor | Added Nov 20, 2021
How to Smoothie!
This summer has been a challenge after a family member with celiac disease had a gluten exposure (Click here to read more about celiac disease). Gluten damages the small intestine villi (see 5 Facts You Probably Didn't Know About Your Small Intestines), which are essential for nutrition absorption. For overprostate cancer | Medivizor | source: Medivizor | Added Nov 14, 2021
Quick Guide: Understanding the Importance of the FDA's Keytruda Approval
In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ. In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features. Achieving this goal is closer than you think!
